Patents by Inventor Christopher Brooks

Christopher Brooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180175382
    Abstract: The present disclosure relates to a method of making core-shell and yolk-shell nanoparticles, and to electrodes comprising the same. The core-shell and yolk-shell nanoparticles and electrodes comprising them are suitable for use in electrochemical cells, such as fluoride shuttle batteries. The shell may protect the metal core from oxidation, including in an electrochemical cell. In some embodiments, an electrochemically active structure includes a dimensionally changeable active material forming a particle that expands or contracts upon reaction with or release of fluoride ions. One or more particles are at least partially surrounded with a fluoride-conducting encapsulant and optionally one or more voids are formed between the active material and the encapsulant using sacrificial layers or selective etching. When the electrochemically active structures are used in secondary batteries, the presence of voids can accommodate dimensional changes of the active material.
    Type: Application
    Filed: December 15, 2017
    Publication date: June 21, 2018
    Inventors: Nam Hawn CHOU, Kaoru Omichi, Ryan McKenney, Qingmin Xu, Christopher Brooks, Simon C. Jones, Isabelle M. Darolles, Hongjin Tan
  • Patent number: 9977574
    Abstract: Techniques for recording and replay of a live conference while still attending the live conference are described. A conferencing system includes a user interface generator, a live conference processing module, and a replay processing module. The user interface generator is configured to generate a user interface that includes a replay control panel and one or more output panels. The live conference processing module is configured to extract information included in received conferencing data that is associated with one or more conferencing modalities, and to display the information in the one or more output panels in a live manner (e.g., as a live conference). The replay processing module is configured to enable information associated with the one or more conferencing modalities corresponding to a time of the conference session prior to live to be presented at a desired rate, possibly different from the real-time rate.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: May 22, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Kori Inkpen Quinn, Rajesh Hegde, Zhengyou Zhang, John Tang, Sasa Junuzovic, Christopher Brooks
  • Publication number: 20170365848
    Abstract: Oxide compositions comprising a modified structure which includes the formula ABOz. The A component may comprise at a cation of least one element selected from the group consisting of Mg, Ca, Sr, Ba, Sc, Y, La, Ce, Pr, Nd, Gd, and Zn, and the B component may comprise a cation of at least one element selected from the group consisting of V, Cr, Mn, Fe, Co, and Ni. Batteries and supercapacitors comprising the oxide compositions of the present disclosure and methods of making the oxide compositions of the present disclosure are also provided.
    Type: Application
    Filed: June 8, 2017
    Publication date: December 21, 2017
    Inventors: Christopher Brooks, Eric Kreidler
  • Publication number: 20170062874
    Abstract: Electrolyte solutions including at least one anhydrous fluoride salt and at least one non-aqueous solvent are presented. The fluoride salt includes an organic cation having a charge center (e.g., N, P, S, or O) that does not possess a carbon in the ?-position or does not possess a carbon in the ?-position having a bound hydrogen. This salt structure facilitates its ability to be made anhydrous without decomposition. Example anhydrous fluoride salts include (2,2-dimethylpropyl)trimethylammonium fluoride and bis(2,2-dimethylpropyl)dimethylammonium fluoride. Combining these fluoride salts with at least one fluorine-containing non-aqueous solvent (e.g., bis(2,2,2-trifluoroethyl)ether; (BTFE)) promotes solubility of the salt within the non-aqueous solvents. The solvent may be a mixture of at least one non-aqueous, fluorine-containing solvent and at least one other non-aqueous, fluorine or non-fluorine containing solvent (e.g., BTFE and propionitrile or dimethoxyethane).
    Type: Application
    Filed: August 4, 2016
    Publication date: March 2, 2017
    Inventors: Simon C. JONES, Victoria K. DAVIS, Christopher M. BATES, Nebojsa MOMCILOVIC, Brett M. SAVOIE, Michael A. WEBB, Thomas F. MILLER, III, Robert H. GRUBBS, Christopher BROOKS, Kaoru OMICHI
  • Publication number: 20160343924
    Abstract: Light emitting devices include an LED that includes an n-type semiconductor layer and a p-type semiconductor layer that is stacked on top of the n-type semiconductor layer. A p-contact metallization stack is on top of the p-type semiconductor layer. An opening extends through the p-type semiconductor layer and the p-contact metallization stack that has a first region that penetrates the p-type semiconductor layer to expose the n-type semiconductor layer and a second region that penetrates the p-contact metallization stack. A bond metal stack is on top of the p-contact metallization stack, and a metal spacer layer is provided between the bond metal stack and the stacked semiconductor layers. The metal spacer layer fills the first region and at least partly fills the second region of the opening so that a lower surface of the bond metal stack is above a top surface of the p-type semiconductor layer.
    Type: Application
    Filed: May 21, 2015
    Publication date: November 24, 2016
    Inventors: Bradley Earl Williams, Christopher Brooks Henderson
  • Publication number: 20150139939
    Abstract: Provided herein are cancer stem cell targeted cancer vaccines and methods for treating and vaccinating against cancer. Also contained herein are regimens by which cancer stem cell targeted cancer vaccines are administered, such regimens comprising peptides, compositions, immunomodulatory agents, and emulsifiers. Also provided are the patient populations to which the regimens are to be administered, and the dosages, schedules, route of administration for the regimens.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 21, 2015
    Applicant: STEMLINE THERAPEUTICS, INC.
    Inventors: Ivan Bergstein, Christopher Brooks, Thomas P. Cirrito
  • Patent number: 8991133
    Abstract: Concrete lumber replacement can be made to exact measurements and cuts. Once placed in the structure, it would make the structure more durable under severe weather conditions. It also deters insects that can destroy the structure over time. Concrete is a fire retardant. If a fire happens, the foundation and frame will still be intact. To date, concrete has never been used in framing. In return, it will conserve trees and lower the overall cost to build the structure.
    Type: Grant
    Filed: November 24, 2006
    Date of Patent: March 31, 2015
    Inventors: Linda J. Franklin, E. Christopher Brooks
  • Patent number: 8984761
    Abstract: A battery identification device which sorts a specialty battery requiring replacement initially by diameter then subsequently by thickness through the interaction of an open channel and ridges which include progressively larger ridges that project into the channel to form zones of progressively diminished thickness.
    Type: Grant
    Filed: March 8, 2014
    Date of Patent: March 24, 2015
    Assignee: Plastics Plus, Inc
    Inventors: Christopher Brooks, Adrian Fournier, Jeremy Mallo, Carl Toti
  • Publication number: 20150079135
    Abstract: Provided herein are methods for treating cancer in a subject comprising administering to the subject a therapeutically effective amount of a peptide derived from the EphA2 protein and/or the IL-13R?2 protein and monitoring the amount of cancer stem cells in said subject. Also provided herein are methods for monitoring the efficacy of an EphA2 peptide-based cancer treatment or an IL-13R?2 peptide-based cancer treatment in a patient with cancer, comprising monitoring the amount of cancer stem cells in said subject prior to, during, and/or following cancer treatment of a patient.
    Type: Application
    Filed: March 19, 2013
    Publication date: March 19, 2015
    Applicant: STEMLINE THERAPEUTICS, INC.
    Inventors: Thomas P. Cirrito, Ivan Bergstein, Christopher Brooks
  • Publication number: 20140325393
    Abstract: Techniques for recording and replay of a live conference while still attending the live conference are described. A conferencing system includes a user interface generator, a live conference processing module, and a replay processing module. The user interface generator is configured to generate a user interface that includes a replay control panel and one or more output panels. The live conference processing module is configured to extract information included in received conferencing data that is associated with one or more conferencing modalities, and to display the information in the one or more output panels in a live manner (e.g., as a live conference). The replay processing module is configured to enable information associated with the one or more conferencing modalities corresponding to a time of the conference session prior to live to be presented at a desired rate, possibly different from the real-time rate.
    Type: Application
    Filed: July 9, 2014
    Publication date: October 30, 2014
    Inventors: Kori Inkpen Quinn, Rajesh Hegde, Zhengyou Zhang, John Tang, Sasa Junuzovic, Christopher Brooks
  • Publication number: 20140249143
    Abstract: Provided are certain compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Anna Lindsey Banka, Janos Botyanszki, Eric Gregory Burroughs, John George Catalano, Wendy Huang Chern, Hamilton D. Dickson, Margaret J. Gartland, Robert Hamatake, Hans Hofland, Jesse Daniel Keicher, Christopher Brooks Moore, John Bradford Shotwell, Matthew David Tallant, Jean-Philippe Therrien, Shihyun You
  • Patent number: 8797380
    Abstract: Techniques for recording and replay of a live conference while still attending the live conference are described. A conferencing system includes a user interface generator, a live conference processing module, and a replay processing module. The user interface generator is configured to generate a user interface that includes a replay control panel and one or more output panels. The live conference processing module is configured to extract information included in received conferencing data that is associated with one or more conferencing modalities, and to display the information in the one or more output panels in a live manner (e.g., as a live conference). The replay processing module is configured to enable information associated with the one or more conferencing modalities corresponding to a time of the conference session prior to live to be presented at a desired rate, possibly different from the real-time rate, if a replay mode is selected in the replay control panel.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: August 5, 2014
    Assignee: Microsoft Corporation
    Inventors: Kori Inkpen Quinn, Rajesh Hegde, Zhengyou Zhang, John Tang, Sasa Junuzovic, Christopher Brooks
  • Patent number: 8761450
    Abstract: A computer-implemented method of generating a model from a set of images. The method comprises processing a plurality of data items, each data item representing an image of said set of images, to determine variability between said plurality of data items; and generating model data representing said model based upon said data items and said variability, wherein the influence of each of said data items upon the generated model is determined by a relationship between a respective one of said data items and said variability.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: June 24, 2014
    Assignee: 4Sight Imaging Limited
    Inventors: Andrew Hill, Christopher Brook Jackson
  • Patent number: 8633236
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: January 21, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, Jr., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Publication number: 20130053436
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: September 12, 2012
    Publication date: February 28, 2013
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, JR., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Patent number: 8329928
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: December 11, 2012
    Assignee: Cytokinetics, Incorporated
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, Jr., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Patent number: D766024
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: September 13, 2016
    Assignee: Plastics Plus, Inc.
    Inventor: Christopher Brooks
  • Patent number: D774337
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: December 20, 2016
    Assignee: Plastics Plus, Inc.
    Inventor: Christopher Brooks
  • Patent number: D777491
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: January 31, 2017
    Assignee: Plastics Plus Inc.
    Inventor: Christopher Brooks
  • Patent number: D820068
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: June 12, 2018
    Assignee: Plastics Plus Inc.
    Inventor: Christopher Brooks